Tyrosine Kinase Inhibitors |
Imatinib* |
Sunitinib* |
Regorafenib* |
Nilotinib* |
Sorafenib* |
Masitinib |
Vatalanib |
Dovitinib |
Pazopanib* |
Cedarinib |
Crenolanib |
Hsp90 Inhibitors |
BIIB021 |
AT13387 |
AUY922 |
Ganestespib (STA-9090) |
PI3K–AKT-mTOR inhibitors |
Perifosine |
Everolimus* |
Sirolimus* |
Temsirolimus* |
Monoclonal Antibodies |
Olaratumab |
Insulin-like growth factor 1 receptor inhibitors. |
OSI-906 (Linsitinib) |
Commercially available